rs4656345

GWAS Catalog Trait Associations (1)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

QT interval

Allele A
OR 4.73
p 1.0e-19
N 71,061
Large GWAS
European

Research that mentions this SNP (1)

NOS1AP variant associated with incidence of type 2 diabetes in calcium channel blocker users in the Atherosclerosis Risk in Communities (ARIC) study
AssociationN=11,945Chu AY et al.(2010)· Diabetologia

In the ARIC study of 9,221 white and 2,724 African-American participants over 9 years of follow-up, rs10494366 in NOS1AP was validated as associated with reduced incidence of type 2 diabetes in calcium channel blocker (CCB) users (HR 0.57, 95% CI 0.35-0.92, p=0.016). The G allele was also associated with lower fasting glucose levels (p=0.037) in CCB users, and the association remained significant in time-dependent analysis (HR 0.70, 95% CI 0.49-0.99, p=0.036). No other NOS1AP variants showed significant associations after multiple testing correction.

Traits studied:Fasting glucoseQT intervalType 2 diabetes

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…